Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
35,393,481
Total 13F shares
1,267,947
Share change
+1,267,947
Total reported value
$3,838,114
Price per share
$3.02
Number of holders
11
Value change
+$3,838,114
Number of buys
11

Quarterly Holders Quick Answers

What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q3 2023

As of 30 Sep 2023, Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,267,947 shares. The largest 10 holders included FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), RHUMBLINE ADVISERS, UBS Group AG, and GROUP ONE TRADING, L.P.. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.